Fig. 3From: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison studySankey diagrams demonstrating the difference in treatment regimens received by each group, including (a) the entire cohort (excluding 11 of the 208 patients for whom treatment was not known). b USTS cases, of whom only 10/28 (36%) commenced treatment, in contrast to (c) comparison patients. Of whom 131/134(98%) commenced active therapy. Of those that underwent PDS, only four did not receive adjuvant chemotherapy. Of the 127 patients who underwent chemotherapy, 103 (81%) completed all 6 cyclesBack to article page